Regeneron Up Over 4%, on Pace for Highest Close Since September 2017 -- Data Talk
05 March 2020 - 4:29AM
Dow Jones News
Regeneron Pharmaceuticals, Inc. (REGN) is currently at $482.04,
up $20.49 or 4.44%
-- Would be highest close since Sept. 6, 2017, when it closed at
$500.22
-- Up 28.38% year-to-date
-- Down 18.63% from its all-time closing high of $592.40 on Aug.
5, 2015
-- Up 13.77% from 52 weeks ago (March 6, 2019), when it closed
at $423.69
-- Would be a new 52 week closing high
-- Up 76.27% from its 52 week closing low of $273.46 on Sept.
27, 2019
-- Traded as high as $484.85; highest intraday level since Sept.
7, 2017, when it hit $489.00
-- Up 5.05% at today's intraday high; largest intraday percent
increase since Feb. 25, 2020, when it rose as much as 7.57%
-- Third best performer in the Nasdaq 100 today
All data as of 11:53:00 AM
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 04, 2020 12:14 ET (17:14 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Jul 2023 to Jul 2024